Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2015 Feb 5;35(4):829–837. doi: 10.1161/ATVBAHA.114.304457

Figure 3.

Figure 3

A) Leukocyte counts: Vein wall morphometrics were quantified at the vein wall/thrombus interphase (cells/5 high power fields). B) Circulating Leukocyte Count. Of note, P-selectin administration did not decrease circulating leukocyte counts. References: control group in red; anti-P-selectin aptamer prophylaxis in green; anti-P-selectin aptamer treatment in blue; anti-VWF aptamer prophylaxis in yellow; anti-P-selectin aptamer treatment in pink; LMWH treatment in grey. Base: Baseline; T6: 6 hours after thrombosis, D2: two days after thrombosis; D6: six days after thrombosis; D14: fourteen days after thrombosis; D21: twenty-one days after thrombosis.